Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vasudev D et al. – This study documents better long–term preservation of open angle and IOP control in eyes receiving bevacizumab along with PRP. The authors stress that NVG is still associated with poor visual acuity outcomes.

 

Related Articles

Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09    Relevance Score: 93%

Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09    Relevance Score: 92%

Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09    Relevance Score: 91%

Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09    Relevance Score: 91%

Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09    Relevance Score: 91%

Today in Clinical Pharmacology...keeping you current

Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09

Retinal Arteriolar Vascular Reactivity in Untreated and Progressive Primary Open Angle Glaucoma
Investigative Ophthalmology and Visual Science, 11/20/09

"Treat and Extend" Dosing of Intravitreal Antivascular Endothelial Growth Factor Therapy for Type 3 Neovascularization/Retinal Angiomatous Proliferation
Retina, 11/20/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address